Edition:
India

Julie Steenhuysen

Hydroxychloroquine combination risky for cancer patients with COVID-19 - study

29 May 2020

CHICAGO Cancer patients with COVID-19 who were treated with a drug combination promoted by U.S. President Donald Trump to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone, U.S. researchers reported on Thursday.

Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmakers

27 May 2020

NEW YORK U.S. pharmacy chains are preparing a big push for flu vaccinations when the season kicks off in October, hoping to curb tens of thousands of serious cases that could coincide with a second wave of coronavirus infections.

Merck to buy Austrian vaccine maker as it jumps into COVID-19 race

27 May 2020

CHICAGO Merck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines. | Video

ENFOQUE-Miedo a segunda ola de coronavirus impulsa vacunación EEUU contra la gripe

26 May 2020

NUEVA YORK, 26 mayo Las farmacéuticas de Estados Unidos preparan una gran campaña de vacunación contra la gripe para octubre, cuando comienza la temporada en ese país, con la esperanza de evitar decenas de miles de casos graves que podrían coincidir con una segunda oleada de infecciones por coronavirus.

FOCUS-Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmakers

26 May 2020

NEW YORK, May 26 U.S. pharmacy chains are preparing a big push for flu vaccinations when the season kicks off in October, hoping to curb tens of thousands of serious cases that could coincide with a second wave of coronavirus infections.

FOCUS-Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmakers

26 May 2020

By Caroline Humer and Julie Steenhuysen NEW YORK U.S. pharmacy chains are preparing a big push for flu vaccinations when the season kicks off in October, hoping to curb tens of thousands of serious cases that could coincide with a second wave of coronavirus infections.

Merck leaps into COVID-19 development fray with vaccine, drug deals

26 May 2020

By Julie Steenhuysen and Michael Erman CHICAGO Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.

Merck leaps into COVID-19 development fray with vaccine, drug deals

26 May 2020

By Julie Steenhuysen and Michael Erman CHICAGO Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.

ENFOQUE-El miedo a una segunda ola de coronavirus impulsa la vacunación contra la gripe

26 May 2020

NUEVA YORK, 26 may Las cadenas farmacéuticas de Estados Unidos están preparando una gran campaña de vacunación contra la gripe cuando comience la temporada en octubre, con la esperanza de evitar decenas de miles de casos graves que podrían coincidir con una segunda oleada de infecciones por coronavirus.

FOCUS-Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmakers

26 May 2020

NEW YORK, May 26 U.S. pharmacy chains are preparing a big push for flu vaccinations when the season kicks off in October, hoping to curb tens of thousands of serious cases that could coincide with a second wave of coronavirus infections.

World News